Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 13, 2025BiosensorsOpen Access

Artificial Intelligence-Based Wearable Sensing Technologies for the Management of Cancer, Diabetes, and COVID-19

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAmit KumarSGShubham GoelACAbhishek Chaudhary

Discussion

Loading...

Member takes

Overview

Analysis reveals AI-based wearable sensors improve outcomes in chronic diseases like diabetes and cancer, suggesting enhanced patient monitoring.

Key Points

  • AI-based wearable sensors enhance monitoring capabilities for chronic diseases.
  • Recent advancements review AI wearables for glucose and heart rate management in diabetes and COVID-19.
  • Integration of various sensing techniques supports predictive analysis and continuous monitoring.
  • Challenges in accuracy and scalability may impact clinical integration of these technologies.

Cite This Study

Kumar et al. (2025) studied this question.

synapsesocial.com/papers/692523c6c0ce034ddc3550b8https://doi.org/10.3390/bios15110756
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Integrating Artificial Intelligence with Wearable Sensors for Advanced Health Monitoring and Diagnosis2026 · 2 citations
  2. 2Real-time Predictive Health Monitoring using Ai-driven Wearable Sensors: Enhancing Early Detection and Personalized Interventions in Chronic Disease Management2024 · 18 citations
  3. 3AI-Powered Wearable Sensors for Health Monitoring and Clinical Decision Making2025 · 1 citations
  4. 4Integration of artificial intelligence and wearable technology in the management of diabetes and prediabetes2025
  5. 5Combining Wearable Sensors and Artificial Intelligence in Cardiovascular Medicine2025 · 10 citations